This finding is consistent with the results of the SURPASS clinical trial program and a meta-analysis of the SURPASS trials which found a similar incidence of hypoglycemia with tirzepatide versus placebo and a low incidence of severe hypoglycemia [14,15,16,17,18,19,20]
For semaglutide (Wegovy), treatment should be discontinued at least two months before a planned pregnancy, while liraglutide (Saxenda) should be stopped before pregnancy (with no specific lead time stated in the SmPC)
Exhibitions Jayuan has been participating in industry exhibitions such as CPHI, API, PMEC and Vitafoods Asia for many years, exhibiting its core products and latest technology advances for in-depth discussions and collaborations with pharmaceutical companies, research institutions and industry experts from around the world
Jumping from 0.25 mg directly to 1 mg, which can happen with a single concentration mix-up, commonly causes severe nausea, vomiting, and in some cases, serious gastrointestinal distress